Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) EBT: 2020-2024

Historic EBT for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$14.6 million.

  • Journey Medical's EBT rose 3.14% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year increase of 53.09%. This contributed to the annual value of -$14.6 million for FY2024, which is 302.29% down from last year.
  • According to the latest figures from FY2024, Journey Medical's EBT is -$14.6 million, which was down 302.29% from -$3.6 million recorded in FY2023.
  • Journey Medical's 5-year EBT high stood at $7.2 million for FY2020, and its period low was -$42.4 million during FY2021.
  • Its 3-year average for EBT is -$15.9 million, with a median of -$14.6 million in 2024.
  • As far as peak fluctuations go, Journey Medical's EBT tumbled by 692.20% in 2021, and later spiked by 87.72% in 2023.
  • Yearly analysis of 5 years shows Journey Medical's EBT stood at $7.2 million in 2020, then slumped by 692.20% to -$42.4 million in 2021, then surged by 30.21% to -$29.6 million in 2022, then spiked by 87.72% to -$3.6 million in 2023, then tumbled by 302.29% to -$14.6 million in 2024.